“CARDIAC STEM CELL WITH TNFR1-BLOCKER AND NRG1/ERB-B4 INDUCTION AS A REJUVENATION THERAPY OF HEART FAILURE DUE TO ISCHEMIC HEART DISEASE”, JIMKI, vol. 9, no. 2, pp. 84–94, Nov. 2021, doi: 10.53366/jimki.v9i2.442.